Cite
HARVARD Citation
Gorse, G. et al. (2022). A phase 1 dose-sparing, randomized clinical trial of seasonal trivalent inactivated influenza vaccine combined with MAS-1, a novel water-in-oil adjuvant/delivery system. Vaccine. 40 (9), pp. 1271-1281. [Online].